Primecap Management
ADVM

Primecap Management’s Adverum Biotechnologies ADVM Stock Holding History

Primecap Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,500
Closed -$2.48M – 293
2019
Q3 		$2.48M Sell
45,500
-62,700
-58% -$7.07M ﹤0.01% 267
2019
Q2 		$12.9M Buy
108,200
+3,000
+3% +$248K 0.01% 235
2019
Q1 		$5.51M Hold
105,200
– – ﹤0.01% 253
2018
Q4 		$3.31M Buy
105,200
+21,690
+26% +$882K ﹤0.01% 261
2018
Q3 		$5.05M Buy
83,510
+33,170
+66% +$1.86M ﹤0.01% 261
2018
Q2 		$2.67M Hold
50,340
– – ﹤0.01% 268
2018
Q1 		$2.92M Hold
50,340
– – ﹤0.01% 261
2017
Q4 		$1.76M Buy
50,340
+1,890
+4% +$62.2K ﹤0.01% 271
2017
Q3 		$1.77M Sell
48,450
-620
-1% -$17.2K ﹤0.01% 265
2017
Q2 		$1.23M Buy
49,070
+5,030
+11% +$138K ﹤0.01% 277
2017
Q1 		$1.19M Buy
44,040
+1,480
+3% +$42.1K ﹤0.01% 271
2016
Q4 		$1.23M Sell
42,560
-70
-0.2% -$2.29K ﹤0.01% 268
2016
Q3 		$1.75M Buy
42,630
+240
+0.6% +$9.11K ﹤0.01% 262
2016
Q2 		$1.34M Sell
42,390
-310
-0.7% -$14K ﹤0.01% 263
2016
Q1 		$2.21M Buy
42,700
+4,920
+13% +$275K ﹤0.01% 255
2015
Q4 		$3.6M Buy
37,780
+540
+1% +$47.4K ﹤0.01% 247
2015
Q3 		$3.07M Buy
37,240
+30,410
+445% +$3.89M ﹤0.01% 254
2015
Q2 		$1.11M Buy
6,830
+4,900
+254% +$1.65M ﹤0.01% 255
2015
Q1 		$782K Sell
1,930
-1,870
-49% -$791K ﹤0.01% 253
2014
Q4 		$2.05M Sell
3,800
-790
-17% -$305K ﹤0.01% 245
2014
Q3 		$1.57M Buy
+4,590
New +$1.37M ﹤0.01% 246

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KL
Kam Lawrence $97.4M AUM
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management's ADVM Position: Q4 2019 in Review

Primecap Management sold out of Adverum Biotechnologies (ADVM) in Q4 2019, closing a stake of 45,500 shares — an estimated $2.48M sold.

Primecap Management first reported a position in ADVM in Q3 2014 and held it in 21 quarters. The position peaked at $12.9M in Q2 2019. 116 funds tracked by Wall St. Rank hold ADVM as of Q4 2019.

  • Primecap Management reported no remaining Adverum Biotechnologies position as of Q4 2019 after selling out during the quarter.
  • Primecap Management sold 45,500 Adverum Biotechnologies shares in Q4 2019, an estimated $2.48M.
  • Primecap Management first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 21 quarters.
  • Primecap Management's Adverum Biotechnologies position peaked at $12.9M in Q2 2019.
  • 116 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2019.

Based on Primecap Management's 13F filing for Q4 2019, filed 14 Feb 2020.